Insulet (PODD) EBT Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,471.00 |
| Dec 31, 2025 | 2,540.00 |
| Sep 30, 2025 | 1,166.00 |
| Jun 30, 2025 | -331.00 |
| Mar 31, 2025 | 978.00 |
| Dec 31, 2024 | 1,540.00 |
| Sep 30, 2024 | 1,467.00 |
| Jun 30, 2024 | 939.00 |
| Mar 31, 2024 | 948.00 |
| Dec 31, 2023 | 1,458.00 |
| Sep 30, 2023 | 1,118.00 |
| Jun 30, 2023 | 822.00 |
| Mar 31, 2023 | 1,191.00 |
| Dec 31, 2022 | 1,135.00 |
| Sep 30, 2022 | 6.00 |
| Jun 30, 2022 | -507.00 |
| Mar 31, 2022 | 2,158.00 |
| Dec 31, 2021 | 1,886.00 |
| Sep 30, 2021 | 863.00 |
| Jun 30, 2021 | -602.00 |
| Mar 31, 2021 | 1,320.00 |
| Dec 31, 2020 | 1,131.00 |
| Sep 30, 2020 | 3,086.00 |
| Jun 30, 2020 | 3,618.00 |
| Mar 31, 2020 | 2,032.00 |
| Dec 31, 2019 | 589.00 |
| Sep 30, 2019 | 1,501.00 |
| Jun 30, 2019 | 4,143.00 |
| Mar 31, 2019 | 1,173.00 |
| Dec 31, 2018 | 1,046.00 |
| Sep 30, 2018 | 3,606.00 |
| Jun 30, 2018 | 1,628.00 |
| Mar 31, 2018 | 1,332.00 |
| Dec 31, 2017 | 1,219.00 |
| Sep 30, 2017 | 2,090.00 |
| Jun 30, 2017 | 2,125.00 |
| Mar 31, 2017 | 2,114.00 |
| Dec 31, 2016 | 2,147.00 |
| Sep 30, 2016 | 2,730.00 |
| Jun 30, 2016 | 5,539.00 |
| Mar 31, 2016 | 2,177.00 |
| Dec 31, 2015 | 5,629.00 |
| Sep 30, 2015 | 2,240.00 |
| Jun 30, 2015 | 3,129.00 |